A new diagnostic test for brain tumours can deliver results in hours, cutting the waiting period from weeks to a matter of hours, according to a recent report from BBC Health.

For patients suspected of having a brain tumour, the standard pathway often involves a series of imaging scans, biopsies and specialist consultations that can take several weeks to complete. During this time, patients experience uncertainty and may have to delay the start of potentially life‑saving treatments.

The rapid test, developed by a research team, uses a minimally invasive sample to identify tumour‑specific markers and can provide a definitive diagnosis in a fraction of the time required by conventional methods. By shortening the diagnostic window, doctors can begin treatment plans sooner and patients can avoid prolonged periods of anxiety.

If the test is adopted widely, it could become a standard part of the diagnostic work‑up for brain tumours, improving outcomes and streamlining care pathways. Further studies will evaluate its accuracy and cost‑effectiveness, but the initial findings suggest a significant shift in how clinicians approach brain tumour diagnosis.

The shift from weeks to hours also has implications for healthcare resource allocation. Shorter diagnostic times reduce the need for repeated imaging and specialist appointments, potentially freeing up clinic slots for other patients. Moreover, earlier treatment initiation may improve survival rates and quality of life, as delays are known to negatively impact outcomes in many tumour types.